Home/Filings/4/0001127602-16-048020
4//SEC Filing

MERIDIAN BIOSCIENCE INC 4

Accession 0001127602-16-048020

CIK 0000794172operating

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 11:43 AM ET

Size

6.6 KB

Accession

0001127602-16-048020

Insider Transaction Report

Form 4
Period: 2016-03-24
Elagin Vecheslav A
Sr VP, Research & Development
Transactions
  • Award

    Stock Options (Right to Buy)

    2016-03-24+1,0001,000 total
    Exercise: $19.56Exp: 2026-03-24Common Stock (1,000 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    75
  • Common Stock

    54,459
Footnotes (1)
  • [F1]These options are awarded under the 2012 Stock Incentive Plan in connection with the Company's acquisition of Magellan Diagnostics, Inc. and vest in four equal installments from the date of grant (i.e., 25% per year until fully vested on March 24, 2020).

Issuer

MERIDIAN BIOSCIENCE INC

CIK 0000794172

Entity typeoperating
IncorporatedOH

Related Parties

1
  • filerCIK 0000794172

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 11:43 AM ET
Size
6.6 KB